Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

Completed · Phase 1

Conditions studied: Hepatic Impairment, Healthy Volunteers

In brief

The purpose of this study is to assess the drug levels and safety of golcadomide (BMS-986369) in adult participants with moderate and severe Hepatic Impairment (HI), and in matched healthy control participants with normal hepatic function.

Key facts

Study ID

NCT06535399

Run by

Celgene

People needed

29

Starts

2024-08-15

Expected to finish

2025-11-12

Last updated by the study team

2026-01-23

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

Where it is running

• Local Institution - 0001 — Chandler, Arizona, United States
• Local Institution - 0002 — Orlando, Florida, United States
• Texas Liver Institute — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.